Catharina Hospital, Eindhoven, The Netherlands Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2006
NCT00377780
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Catharina Hospital, Eindhoven, The Netherlands | Laurence J.C. van Warmerdam

Active Ingredients

Drugs in Phase 2 Trials (3)

docetaxel (taxotere) (1 trial)

doxorubicin (Doxil) (1 trial)

trastuzumab (herceptin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Neoplasm Metastasis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 3